{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T21:44:19Z","timestamp":1795211059675,"version":"4.10.3"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T00:00:00Z","timestamp":1610668800000},"content-version":"vor","delay-in-days":14,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"UK Biobank Resource","award":["33601"],"award-info":[{"award-number":["33601"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,3,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Biallelic Parkin (PRKN) mutations cause autosomal recessive Parkinson\u2019s disease (PD); however, the role of monoallelic PRKN mutations as a risk factor for PD remains unclear. We investigated the role of single heterozygous PRKN mutations in three large independent case-control cohorts totalling 10\u2009858 PD cases and 8328 controls. Overall, after exclusion of biallelic carriers, single PRKN mutations were more common in PD than controls conferring a &amp;gt;1.5-fold increase in the risk of PD [P-value (P)\u2009=\u20090.035], with meta-analysis (19\u2009574 PD cases and 468\u2009488 controls) confirming increased risk [Odds ratio (OR)\u2009=\u20091.65, P\u2009=\u20093.69E-07]. Carriers were shown to have significantly younger ages at the onset compared with non-carriers (NeuroX: 56.4 vs. 61.4\u00a0years; exome: 38.5 vs. 43.1\u00a0years). Stratifying by mutation type, we provide preliminary evidence for a more pathogenic risk profile for single PRKN copy number variant (CNV) carriers compared with single nucleotide variant carriers. Studies that did not assess biallelic PRKN mutations or consist of predominantly early-onset cases may be biasing these estimates, and removal of these resulted in a loss of association (OR\u2009=\u20091.23, P\u2009=\u20090.614; n\u2009=\u20094). Importantly, when we looked for additional CNVs in 30% of PD cases with apparent monoallellic PRKN mutations, we found that 44% had biallelic mutations, suggesting that previous estimates may be influenced by cryptic biallelic mutation status. While this study supports the association of single PRKN mutations with PD, it highlights confounding effects; therefore, caution is needed when interpreting current risk estimates. Together, we demonstrate that comprehensive assessment of biallelic mutation status is essential when elucidating PD risk associated with monoallelic PRKN mutations.<\/jats:p>","DOI":"10.1093\/hmg\/ddaa273","type":"journal-article","created":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T22:58:37Z","timestamp":1610492317000},"page":"78-86","source":"Crossref","is-referenced-by-count":63,"title":["Assessing the relationship between monoallelic\n                    <i>PRKN<\/i>\n                    mutations and Parkinson\u2019s risk"],"prefix":"10.1093","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7103-6671","authenticated-orcid":false,"given":"Steven J","family":"Lubbe","sequence":"first","affiliation":[{"name":"Ken and Ruth Davee Department of Neurology and Simpson Querrey Center for Neurogenetics, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernabe I","family":"Bustos","sequence":"additional","affiliation":[{"name":"Ken and Ruth Davee Department of Neurology and Simpson Querrey Center for Neurogenetics, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Hu","sequence":"additional","affiliation":[{"name":"Ken and Ruth Davee Department of Neurology and Simpson Querrey Center for Neurogenetics, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri","family":"Krainc","sequence":"additional","affiliation":[{"name":"Ken and Ruth Davee Department of Neurology and Simpson Querrey Center for Neurogenetics, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresita","family":"Joseph","sequence":"additional","affiliation":[{"name":"Department of Clinical and Movement Neurosciences, and UCL Movement Disorders Centre, Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Hehir","sequence":"additional","affiliation":[{"name":"National Hospital for Neurology and Neurosurgery, Queen Square, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Clinical and Movement Neurosciences, and UCL Movement Disorders Centre, Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijia","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Clinical and Movement Neurosciences, and UCL Movement Disorders Centre, Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Escott-Price","sequence":"additional","affiliation":[{"name":"Institute of Psychological Medicine and Clinical Neurosciences, Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Cardiff University School of Medicine, Cardiff, CF24 4HQ, UK"},{"name":"Dementia Research Institute at Cardiff, Cardiff University, Cardiff, CF24 4HQ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel M","family":"Williams","sequence":"additional","affiliation":[{"name":"Institute of Psychological Medicine and Clinical Neurosciences, Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Cardiff University School of Medicine, Cardiff, CF24 4HQ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis","family":"Blauwendraat","sequence":"additional","affiliation":[{"name":"Molecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew B","family":"Singleton","sequence":"additional","affiliation":[{"name":"Molecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huw R","family":"Morris","sequence":"additional","affiliation":[{"name":"Department of Clinical and Movement Neurosciences, and UCL Movement Disorders Centre, Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for International Parkinson\u2019s Disease Genomics Consortium (IPDGC)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,1,15]]},"reference":[{"key":"2021040906161833600_ref1","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","article-title":"Identification of novel risk loci, causal insights, and heritable risk for Parkinson\u2019s disease: a meta-analysis of genome-wide association studies","volume":"18","author":"Nalls","year":"2019","journal-title":"Lancet Neurol."},{"key":"2021040906161833600_ref2","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00415-013-7003-2","article-title":"Recent advances in Parkinson\u2019s disease genetics","volume":"261","author":"Lubbe","year":"2014","journal-title":"J. Neurol."},{"key":"2021040906161833600_ref3","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S1474-4422(07)70174-6","article-title":"Deciphering the role of heterozygous mutations in genes associated with parkinsonism","volume":"6","author":"Klein","year":"2007","journal-title":"Lancet Neurol."},{"key":"2021040906161833600_ref4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/ana.21039","article-title":"Heterozygous parkin point mutations are as common in control subjects as in Parkinson\u2019s patients","volume":"61","author":"Kay","year":"2007","journal-title":"Ann. Neurol."},{"key":"2021040906161833600_ref5","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1212\/WNL.0b013e3181f4d832","article-title":"A comprehensive analysis of deletions, multiplications, and copy number variations in PARK2","volume":"75","author":"Kay","year":"2010","journal-title":"Neurology"},{"key":"2021040906161833600_ref6","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1002\/mds.10601","article-title":"Parkin variants in North American Parkinson\u2019s disease: cases and controls","volume":"18","author":"Lincoln","year":"2003","journal-title":"Mov. Disord."},{"key":"2021040906161833600_ref7","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.parkreldis.2008.11.014","article-title":"Frequency of heterozygous Parkin mutations in healthy subjects: need for careful prospective follow-up examination of mutation carriers","volume":"15","author":"Br\u00fcggemann","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"key":"2021040906161833600_ref8","first-page":"5483","article-title":"Additional rare variant analysis in Parkinson\u2019s disease cases with and without known pathogenic mutations: evidence for oligogenic inheritance","volume":"25","author":"Lubbe","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"2021040906161833600_ref9","doi-asserted-by":"crossref","first-page":"210.e1","DOI":"10.1016\/j.neurobiolaging.2015.09.020","article-title":"Analysis of the genetic variability in Parkinson\u2019s disease from Southern Spain","volume":"37","author":"Bandr\u00e9s-Ciga","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"2021040906161833600_ref10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13024-016-0097-0","article-title":"Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson\u2019s Disease","volume":"11","author":"Benitez","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"2021040906161833600_ref11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2377-8-1","article-title":"Analysis of Parkinson disease patients from Portugal for mutations in SNCA, PRKN, PINK1 and LRRK2","volume":"8","author":"Bras","year":"2008","journal-title":"BMC Neurol."},{"key":"2021040906161833600_ref12","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1136\/jmg.2008.063917","article-title":"Parkin and PINK1 mutations in early-onset Parkinson\u2019s disease: comprehensive screening in publicly available cases and control","volume":"46","author":"Brooks","year":"2009","journal-title":"J. Med. Genet."},{"key":"2021040906161833600_ref13","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/archneur.63.4.548","article-title":"Case-control study of the Parkin gene in early-onset Parkinson disease","volume":"63","author":"Clark","year":"2006","journal-title":"Arch. Neurol."},{"key":"2021040906161833600_ref14","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.clineuro.2016.07.005","article-title":"Mutation analysis of the PARKIN, PINK1, DJ1, and SNCA genes in Turkish early-onset Parkinson\u2019s patients and genotype-phenotype correlations","volume":"148","author":"Erer","year":"2016","journal-title":"Clin. Neurol. Neurosurg."},{"key":"2021040906161833600_ref15","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1468-1331.2006.01249.x","article-title":"Low frequency of Parkin, Tyrosine Hydroxylase, and GTP Cyclohydrolase I gene mutations in a Danish population of early-onset Parkinson\u2019s Disease","volume":"13","author":"Hertz","year":"2006","journal-title":"Eur. J. Neurol."},{"key":"2021040906161833600_ref16","doi-asserted-by":"crossref","first-page":"5637","DOI":"10.1093\/hmg\/ddv277","article-title":"Heterozygote carriers for CNVs in PARK2 are at increased risk of Parkinson\u2019s disease","volume":"24","author":"Huttenlocher","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"2021040906161833600_ref17","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ana.10179","article-title":"Role of parkin mutations in 111 community-based patients with early-onset parkinsonism","volume":"51","author":"Kann","year":"2002","journal-title":"Ann. Neurol."},{"key":"2021040906161833600_ref18","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/sj.ejhg.5201455","article-title":"PINK1, Parkin, and DJ-1 mutations in Italian patients with early-onset parkinsonism","volume":"13","author":"Klein","year":"2005","journal-title":"Eur. J. Hum. Genet."},{"key":"2021040906161833600_ref19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/jmg.2007.051854","article-title":"Rare heterozygous parkin variants in French early-onset Parkinson disease patients and controls","volume":"45","author":"Lesage","year":"2008","journal-title":"J. Med. Genet."},{"key":"2021040906161833600_ref20","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/mds.22287","article-title":"Genotypic and phenotypic characteristics of Dutch patients with early onset Parkinson\u2019s disease","volume":"24","author":"Macedo","year":"2009","journal-title":"Mov. Disord."},{"key":"2021040906161833600_ref21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1155\/2013\/597158","article-title":"Genetic analysis of PARK2 and PINK1 genes in Brazilian patients with early-onset Parkinson\u2019s disease","volume":"35","author":"Moura","year":"2013","journal-title":"Dis. Markers"},{"key":"2021040906161833600_ref22","doi-asserted-by":"crossref","first-page":"e20988","DOI":"10.1371\/journal.pone.0020988","article-title":"Copy number variation in familial Parkinson disease","volume":"6","author":"Pankratz","year":"2011","journal-title":"PLoS One"},{"key":"2021040906161833600_ref23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1600-0404.2005.00532.x","article-title":"Parkin gene variations in late-onset Parkinson\u2019s disease: comparison between Norwegian and German cohorts","volume":"113","author":"Schlitter","year":"2006","journal-title":"Acta Neurol. Scandinavica"},{"key":"2021040906161833600_ref24","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/humu.20626","article-title":"Genomewide SNP assay reveals mutations underlying Parkinson disease","volume":"29","author":"Simon-Sanchez","year":"2008","journal-title":"Hum. Mutat."},{"key":"2021040906161833600_ref25","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.parkreldis.2007.10.003","article-title":"Parkin analysis in early onset Parkinson\u2019s disease","volume":"14","author":"Sironi","year":"2008","journal-title":"Parkinsonism Relat. Disord."},{"key":"2021040906161833600_ref26","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/mds.26845","article-title":"Detection of genomic rearrangements from targeted resequencing data in Parkinson\u2019s disease patients","volume":"32","author":"Spataro","year":"2017","journal-title":"Mov. Disord."},{"key":"2021040906161833600_ref27","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/mds.10703","article-title":"Parkinson\u2019s disease in Ireland: clinical presentation and genetic heterogeneity in patients with parkin mutations","volume":"19","author":"Wiley","year":"2004","journal-title":"Mov. Disord."},{"key":"2021040906161833600_ref28","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1212\/WNL.0b013e3181af7a33","article-title":"Parkin dosage mutations have greater pathogenicity in familial PD than simple sequence mutations","volume":"73","author":"Pankratz","year":"2009","journal-title":"Neurology"},{"key":"2021040906161833600_ref29","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1093\/hmg\/ddz080","article-title":"The landscape of Parkin variants reveals pathogenic mechanisms and therapeutic targets in Parkinson\u2019s disease","volume":"28","author":"Yi","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"2021040906161833600_ref30","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1212\/WNL.58.8.1239","article-title":"Evaluation of 50 probands with early-onset Parkinson\u2019s disease for Parkin mutations","volume":"58","author":"Hedrich","year":"2002","journal-title":"Neurology"},{"key":"2021040906161833600_ref31","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/ajmg.10525","article-title":"Complex relationship between Parkin mutations and Parkinson disease","volume":"114","author":"West","year":"2002","journal-title":"Am. J. Med. Genet. Neuropsychiatr. Genet."},{"key":"2021040906161833600_ref32","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1001\/archneur.63.6.826","article-title":"Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study","volume":"63","author":"Sun","year":"2006","journal-title":"Arch. Neurol."},{"key":"2021040906161833600_ref33","first-page":"1605.e7-12","article-title":"Neuro X, a fast and efficient genotyping platform for investigation of neurodegenerative diseases","volume":"36","author":"Nalls","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"2021040906161833600_ref34","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1101\/gr.6861907","article-title":"Penn CNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data","volume":"17","author":"Wang","year":"2007","journal-title":"Genome Res."},{"key":"2021040906161833600_ref35","doi-asserted-by":"crossref","first-page":"168.e1","DOI":"10.1016\/j.neurobiolaging.2020.03.003","article-title":"Comprehensive assessment of PINK1 variants in Parkinson\u2019s disease","volume":"91","author":"Krohn","year":"2020","journal-title":"Neurobiol. Aging"},{"key":"2021040906161833600_ref36","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1200\/JCO.2008.21.6853","article-title":"Clinical implications of the colorectal cancer risk associated with MUTYH mutation","volume":"27","author":"Lubbe","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"2021040906161833600_ref37","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1073\/pnas.1914912117","article-title":"Cystic fibrosis carriers are at increased risk for a wide range of cystic fibrosis-related conditions","volume":"117","author":"Miller","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2021040906161833600_ref38","doi-asserted-by":"crossref","first-page":"159.e5","DOI":"10.1016\/j.neurobiolaging.2017.12.012","article-title":"Insufficient evidence for pathogenicity of SNCA His50Gln (H50Q) in Parkinson\u2019s disease","volume":"64","author":"Blauwendraat","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"2021040906161833600_ref39","volume-title":"Meta-analysis, Decision Analysis and Cost-Effectiveness Analysis","author":"Petitti","year":"1994"},{"key":"2021040906161833600_ref40","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat. Med."}],"container-title":["Human Molecular Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/hmg\/advance-article-pdf\/doi\/10.1093\/hmg\/ddaa273\/36304945\/ddaa273.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/hmg\/article-pdf\/30\/1\/78\/36989224\/ddaa273.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/hmg\/article-pdf\/30\/1\/78\/36989224\/ddaa273.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T03:30:08Z","timestamp":1617939008000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/hmg\/article\/30\/1\/78\/6097030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,1]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1,15]]},"published-print":{"date-parts":[[2021,3,25]]}},"URL":"https:\/\/doi.org\/10.1093\/hmg\/ddaa273","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.06.26.20138172","asserted-by":"object"}]},"ISSN":["0964-6906","1460-2083"],"issn-type":[{"value":"0964-6906","type":"print"},{"value":"1460-2083","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,1,1]]},"published":{"date-parts":[[2021,1,1]]}}}